Introduction
Imxia AT is a prescription medication that combines three active ingredients: Minoxidil, Azelaic Acid, and Tretinoin. It is available in solution form and is used primarily for the treatment of hair loss.
Uses
Imxia AT is prescribed to individuals who are experiencing hair loss, specifically androgenetic alopecia, which is a common form of hair loss in both men and women. It is believed to work by stimulating hair growth and improving the overall health of the hair follicles.
Dosage and Administration
The recommended dosage of Imxia AT is typically 1 milliliter applied to the scalp twice daily. Follow the instructions provided by your healthcare provider or pharmacist. To apply the solution, part the hair and apply a small amount directly to the affected areas of the scalp. Gently massage the solution into the scalp and wash your hands thoroughly afterward.
Mechanism of Action
Minoxidil, one of the active ingredients in Imxia AT, is thought to work by widening blood vessels and opening potassium channels, which may promote hair growth. Azelaic Acid is believed to have anti-androgenic properties, meaning it may help to reduce the effects of hormones that contribute to hair loss. Tretinoin, the third active ingredient, is thought to promote hair growth by increasing the absorption of Minoxidil into the scalp.
Side Effects
Common side effects may include scalp irritation, dryness, or redness. These side effects are usually mild and improve with continued use. If you experience any severe or persistent side effects, such as severe scalp irritation, rash, or swelling, contact your healthcare provider immediately.
Drug Interactions
inform your healthcare provider about all the medications you are currently taking, including over-the-counter drugs and supplements. Some medications may interact with Imxia AT, potentially affecting its efficacy or increasing the risk of side effects. It is particularly important to avoid using other topical medications or solutions on the scalp while using Imxia AT, unless specifically recommended by your healthcare provider.
Precautions
Before using Imxia AT, inform your healthcare provider about any medical conditions you have, especially if you have a history of heart problems or if you are pregnant or breastfeeding. Imxia AT is not recommended for use in individuals under the age of 18 without medical supervision. Avoid getting the solution in your eyes, nose, or mouth, as it may cause irritation.
Storage
Patient Tips
- Follow the dosage instructions provided by your healthcare provider or pharmacist.
- Avoid using other topical products on the scalp unless recommended by your healthcare provider.
- If you experience any severe side effects or have concerns about the medication, contact your healthcare provider.
- Be patient, as it may take several months of consistent use to see noticeable results.
- If you accidentally get the solution in your eyes, rinse thoroughly with water and seek medical attention if irritation persists.
- If you miss a dose, apply it as soon as you remember, unless it is close to the time for your next dose. In that case, skip the missed dose and continue with your regular dosing schedule.
Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.
References
- Isovaleric acidaemia (NHS UK) [Accessed 25 Jun. 2024] (online) Available at:
- Finacea 15% Gel (Health Professionals SmPC) Available at:
- Azelaic acid topical (Drugs.com) [Accessed 25 Jun. 2024] (online) Available at:
- azelaic acid cream (RX) [Accessed 17 Jun. 2024] (online) Available at:
- Azelaic Acid Topical (MedlinePlus) [Accessed 11 Jun. 2024] (online) Available at:
- Searle T, Ali FR, Al-Niaimi F. The versatility of azelaic acid in dermatology. J Dermatolog Treat. 2022 Mar;33(2):722-732. doi: 10.1080/09546634.2020.1800579. Epub 2020 Aug 4. [Accessed 16 Jun. 2024] Available at:
Reviews
There are no reviews yet.